HIV & AIDS

Global Fund secures deal to slash HIV treatment price

The Global Fund announced Wednesday a deal with generic pharmaceutical manufacturers to significantly slash the price of a cutting-edge HIV drug, in a move it said would save lives.

HIV & AIDS

Study finds HIV stigma persists across US, South

While knowledge and treatment around HIV continues to improve, HIV stigma remains an issue surrounding the disease and the people who live with it, a forthcoming report finds.

HIV & AIDS

Exploring how uncertainty motivates actions in epidemics

In an epidemic, we often focus on three staple metrics: Who does or doesn't have the disease, the rate at which people are contracting the disease, and the mortality rates. What's often left out, as explored in a new book ...

page 14 from 40